The journal Birth Defects Research publishes original research and reviews in areas related to the etiology of adverse developmental and reproductive outcome. In particular the journal is devoted to the publication of original scientific research that contributes to the understanding of the biology of embryonic development and the prenatal causative factors and mechanisms leading to adverse pregnancy outcomes, namely structural and functional birth defects, pregnancy loss, postnatal functional defects in the human population, and to the identification of prenatal factors and biological mechanisms that reduce these risks.
Adverse reproductive and developmental outcomes may have genetic, environmental, nutritional or epigenetic causes. Accordingly, the journal Birth Defects Researchtakes an integrated, multidisciplinary approach in its organization and publication strategy. The journal Birth Defects Research contains separate sections for clinical and molecular teratology, developmental and reproductive toxicology, and reviews in developmental biology to acknowledge and accommodate the integrative nature of research in this field. Each section has a dedicated editor who is a leader in his/her field and who has full editorial authority in his/her area.
The journal Birth Defects Research publishes work in the following areas:
Environmental, genetic and epigenetic factors, and their interactions, causing birth defects demonstrated by clinical epidemiology
Cellular and molecular causative mechanisms of adverse developmental and reproductive outcomes in animal models
Novel insights from genomic, transcriptomic, proteomic and metabolomic approaches
Protective factors in humans and their mechanisms in animal models
Reproductive and developmental toxicity of drugs, chemicals and biotechnology-derived products in organismal, cellular and computational models:
endocrine-mediated reproductive and developmental toxicity;
protocols for evaluating developmental and reproductive toxicity, ranging from computational models to regulatory bioassays;
physiologically based pharmacokinetic (PBPK) mathematical modeling of pregnancy and delivery of agents to the developing organism;
approaches to risk assessment for developmental and reproductive toxicants;
toxicity related to direct exposure in juvenile animals
Topical, multi-disciplinary and state-of-the-art review articles that capture exciting advances in normal and abnormal developmental and reproductive biology
The journal Birth Defects Research is published in twenty issues per year.The journal Birth Defects Research publishes original research and reviews in areas related to the etiology of adverse developmental and reproductive outcome. In particular the journal is devoted to the publication of original scientific research that contributes to the understanding of the biology of embryonic development and the prenatal causative factors and mechanisms leading to adverse pregnancy outcomes, namely structural and functional birth defects, pregnancy loss, postnatal functional defects in the human population, and to the identification of prenatal factors and biological mechanisms that reduce these risks.
Adverse reproductive and developmental outcomes may have genetic, environmental, nutritional or epigenetic causes. Accordingly, the journal Birth Defects Researchtakes an integrated, multidisciplinary approach in its organization and publication strategy. The journal Birth Defects Research contains separate sections for clinical and molecular teratology, developmental and reproductive toxicology, and reviews in developmental biology to acknowledge and accommodate the integrative nature of research in this field. Each section has a dedicated editor who is a leader in his/her field and who has full editorial authority in his/her area.
The journal Birth Defects Research publishes work in the following areas:
Environmental, genetic and epigenetic factors, and their interactions, causing birth defects demonstrated by clinical epidemiology
Cellular and molecular causative mechanisms of adverse developmental and reproductive outcomes in animal models
Novel insights from genomic, transcriptomic, proteomic and metabolomic approaches
Protective factors in humans and their mechanisms in animal models
Reproductive and developmental toxicity of drugs, chemicals and biotechnology-derived products in organismal, cellular and computational models:
endocrine-mediated reproductive and developmental toxicity;
protocols for evaluating developmental and reproductive toxicity, ranging from computational models to regulatory bioassays;
physiologically based pharmacokinetic (PBPK) mathematical modeling of pregnancy and delivery of agents to the developing organism;
approaches to risk assessment for developmental and reproductive toxicants;
toxicity related to direct exposure in juvenile animals
Topical, multi-disciplinary and state-of-the-art review articles that capture exciting advances in normal and abnormal developmental and reproductive biology
The journal Birth Defects Research is published in twenty issues per year.

EDITOR-IN-CHIEF
Michel Vekemans, MD, PhD, Hôpital Necker-Enfants Malades Université Paris Descartes, Paris, France; Email: m_vekemans@yahoo.fr
EDITORS
Christina D. Chambers, PhD, MPH, University of California, San Diego, USA
John M. Rogers, PhD, Environmental Protection Agency, Research Triangle Park, North Carolina, USA
Michiko Watanabe, PhD, Case Western Reserve University, Cleveland, Ohio, USA
ASSOCIATE EDITORS
Simon J. Conway, PhD, Indiana University, Indianapolis, USA
Jan M. Friedman, MD, PhD, British Columbia Childrens Hospital, Vancouver, Canada
Robert Greene, PhD, University of Louisville, Kentucky, USA
Philip Lupo, PhD, Baylor College of Medicine, Houston, Texas, USA
Sarah Obican, MD, University of South Florida, Tampa, USA
Gary M. Shaw, PhD, Stanford University, Stanford, California, USA
EDITORIAL ADVISORY BOARD
Maja Bucan, University of Pennsylvania, Philadelphia, USA
Robert Clark, Artemis Pharmaceutical Research, Lansdale, Pennsylvania, USA
Ralph Cooper, Environmental Protection Agency, Research Triangle Park, North Carolina, USA
Heather Etchevers, INSERM, Marseille, France
Suzanne Fenton, National Institute of Environmental Health Sciences, Durham, North Carolina, USA
Jodie Flaws, University of Illinois, Urbana, USA
Paul Foster, National Institute of Environmental Health Sciences, Durham, North Carolina, USA
Scott Gilbert, Swarthmore College, Pennsylvania, USA
Barbara Hales, McGill University, Montreal, Québec, Canada
Patricia Hunt, Washington State University, Pullman, USA
Robert Kavlock, Environmental Protection Agency, Research Triangle Park, North Carolina, USA
William Kelce, University of Kansas Medical Center, Kansas City, USA
Margaret L. Kirby, Duke University School of Medicine, Durham, North Carolina, USA
Nicole Kleinstreuer, National Institute of Environmental Health Sciences, Durham, North Carolina, USA
Gary Klinefelter, University of North Carolina School of Medicine, Chapel Hill, USA
Thomas Knudsen, Environmental Protection Agency, Research Triangle Park, North Carolina, USA
Susan Laws, National Health and Environmental Effects Research Laboratory, Research Triangle Park, North Carolina, USA
Ling Hong Li, California Environmental Protection Agency, Sacramento, USA
Cecilia W. Lo, University of Pittsburgh, Pennsylvania, USA
Sue Marty, Dow Chemical Company, Midland, Michigan, USA
Barry McIntyre, U.S. Department of Health and Human Services, Washington, DC, USA
Laura E. Mitchell, The University of Texas Health Science Center, Houston, USA
Maximilian Muenke, National Human Genome Research Institute, Bethesda, Maryland, USA
Mary C. Mullins, University of Pennsylvania, Philadelphia, USA
Terence R. S. Ozolins, Queen’s University School of Medicine, Kingston, Ontario, Canada
Louise Parks-Saldutti, Merck Research Laboratories, Harleysville, Pennsylvania, USA
Sonja A. Rasmussen, University of Florida, Gainesville, USA
Luc De Schaepdrijver, Janssen Pharmaceutica, Beerse, Belgium
Lavinia Schuller-Faccini, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
Jane Stewart, Apconix Ltd, Cheshire, UK
Donald Stump, Charles River Laboratories, Ashland, Ohio, USA
Naoto Ueno, The University of Texas MD Anderson Cancer Center, Houston, USA
 
EDITORS EMERITI
Harold Kalter (1968-1976)
Robert L. Brent (1977-1992)
Thomas W. Sadler (1993-1997)
Lewis B. Holmes (1998-2002)
Philip E. Mirkes (2003-2007)
Diana M. Juriloff (2008-2012)
George P. Daston (2003-2017)
Rocky S. Tuan (2003-2017)
SOCIETY PUBLICATIONS COMMITTEE
Brian Enright, PhD, DABT, Chair
Russell S. Kirby, PhD, MS, FACE, Vice Chair
Ludmila Bakhireva, MD, PhD, MPH, Member
Robert M. Cabrera, PhD, Member
James Cray, PhD, Member
Maia L. Green, PhD, Member
Judith W. Henck, PhD, DABT, Member
Julia Y. Hui, PhD, Member
Lutfiya Miller-Pinsler, PhD, DABT, Member
Wendy Nembhard, PhD, MPH, Member
Michel Vekemans, MD, PhD, Editor-in-Chief
Christina D. Chambers, PhD, MPH, Editor
John M. Rogers, PhD, Editor
Michiko Watanabe, PhD, Editor
Shao-yu Chen, PhD, Ad Hoc
Daoyin Dong, PhD, Ad Hoc
Carolyn Kapron, PhD, Ad Hoc
Norbert Makori, BVM, MSc, PhD, DABT, Ad Hoc
Christine Perdan Curran, PhD, President
Mark H. Paalman, PhD, Wiley Representative
SOCIETY COUNCIL 2019-2020
Christine Perdan Curran, PhD, President
Elise Madison Lewis, PhD, Vice President
Susan L. Makris, MSc, Vice President-Elect
Dana L. Shuey, PhD, DABT, Past President
Anthony M. DeLise, PhD, Secretary
Pragati S. Coder, PhD, DABT, Treasurer
Kimberly C. Brannen, PhD, Councilor
Gloria D. Jahnke, DVM, MS, DABT, Councilor
Nicole Churchill Kleinstreuer, PhD, Councilor
Brian Enright, PhD, DABT, Publications Committee Chair
Marcia Lynn Feldkamp, PhD, MSPH, PA, Public Affairs Committee Chair
Linda G. Roberts, PhD, DABT, Communications Committee Chair
Heather Carskaddan, Executive Director, (703) 438-3104